Giuseppe Viale

1987–2025 年に発表

336
論文数
95,406
被引用数
154
h 指数
329
i10 指数

被引用数

Giuseppe Viale の年別被引用数1980 年: 被引用 1 件1981 年: 被引用 2 件1987 年: 被引用 1 件1988 年: 被引用 2 件1989 年: 被引用 3 件1990 年: 被引用 5 件1991 年: 被引用 4 件1992 年: 被引用 2 件1993 年: 被引用 2 件1994 年: 被引用 10 件1995 年: 被引用 20 件1996 年: 被引用 27 件1997 年: 被引用 30 件1998 年: 被引用 45 件1999 年: 被引用 57 件2000 年: 被引用 98 件2001 年: 被引用 116 件2002 年: 被引用 116 件2003 年: 被引用 166 件2004 年: 被引用 139 件2005 年: 被引用 163 件2006 年: 被引用 202 件2007 年: 被引用 217 件2008 年: 被引用 291 件2009 年: 被引用 340 件2010 年: 被引用 456 件2011 年: 被引用 486 件2012 年: 被引用 478 件2013 年: 被引用 573 件2014 年: 被引用 620 件2015 年: 被引用 728 件2016 年: 被引用 793 件2017 年: 被引用 891 件2018 年: 被引用 766 件2019 年: 被引用 2,829 件2020 年: 被引用 3,257 件2021 年: 被引用 3,235 件2022 年: 被引用 2,797 件2023 年: 被引用 2,315 件2024 年: 被引用 3,583 件2025 年: 被引用 1,725 件2026 年: 被引用 78 件1982〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,841 件、この内訳の 21.2%中国: 引用元論文 3,648 件、この内訳の 11.3%イタリア: 引用元論文 2,443 件、この内訳の 7.6%イギリス: 引用元論文 1,869 件、この内訳の 5.8%ドイツ: 引用元論文 1,536 件、この内訳の 4.8%フランス: 引用元論文 1,204 件、この内訳の 3.7%カナダ: 引用元論文 1,065 件、この内訳の 3.3%スペイン: 引用元論文 1,003 件、この内訳の 3.1%オランダ: 引用元論文 931 件、この内訳の 2.9%スイス: 引用元論文 915 件、この内訳の 2.8%日本: 引用元論文 904 件、この内訳の 2.8%オーストラリア: 引用元論文 837 件、この内訳の 2.6%
0%21.2%その他 28.1%

分野

  • Medicine48.7%
  • Biochemistry, Genetics and Molecular Biology40.6%
  • Immunology and Microbiology3.7%
  • Computer Science2.8%
  • Engineering0.9%
  • Agricultural and Biological Sciences0.6%
  • その他2.7%

トピック

  • Breast Cancer Treatment Studies9.4%
  • HER2/EGFR in Cancer Research4.6%
  • Cancer Immunotherapy and Biomarkers4.5%
  • Breast Lesions and Carcinomas3.8%
  • Cancer Cells and Metastasis3%
  • Advanced Breast Cancer Therapies2.6%
  • その他72.1%

共著者

全論文

検索で開く
  1. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 被引用: 1,665

  2. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 被引用: 3,136

  3. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 1,497

  4. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Penna, María Rescigno - Cancer Cell 2021 被引用: 495

  5. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 被引用: 3,715

  6. HER2-Low Breast Cancer: Pathological and Clinical Landscape

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 802

  7. Spatial predictors of immunotherapy response in triple-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2023 被引用: 325

  8. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    著者: , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 被引用: 2,454

  9. A gut-vascular barrier controls the systemic dissemination of bacteria

    著者: , , , , , , , , , , , , - Science 2015 被引用: 701

  10. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 被引用: 803

  11. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René Bernards, Konstantinos Tryfonidis, Emiel J. Rutgers, Martine Piccart - New England Journal of Medicine 2016 被引用: 2,051

  12. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 被引用: 4,267

  13. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  14. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz ほか 10 名 - The Lancet Oncology 2017 被引用: 1,133

  15. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

    著者: , , , , , , , - The Lancet Oncology 2018 被引用: 993

  16. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,399

  17. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , SOUND Trial Group, Fabio Bassi, Fulvio Borella, Pietro Caldarella, Marco Colleoni, Giovanni Corso, Silvia Dellapasqua, Alberta Ferrari, Carlos A. Garcia‐Etienne, Damiano Gentile, Alessandro Germano, L.P. Grosso, Mattia Intra, Monica Iorfida, José Vila, Gennaro Limite, Germana Lissidini, G Macellari, Francesca Magnoni, Ilaria Maugeri, Manuelita Mazza, Emilia Montagna, Paola Naninato, Luca Nicosia, Roberto Orecchia, Alberto F. Pierini, Claudia Rauh, Massimo Rinaldo, Anna Rotili, Nicole Rotmensz, Anna Rita Vento, Veronica Zuber - JAMA Oncology 2023 被引用: 498

  18. Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study

    著者: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 被引用: 386

  19. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  20. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 1,647

  21. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 被引用: 1,837

  22. Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 被引用: 240

  23. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 被引用: 299

  24. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista ほか 454 名 - npj Breast Cancer 2021 被引用: 275